nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP2C8—Sorafenib—thyroid cancer	0.0967	0.177	CbGbCtD
Terbinafine—CYP2C19—Sorafenib—thyroid cancer	0.0811	0.148	CbGbCtD
Terbinafine—CYP1A2—Sorafenib—thyroid cancer	0.0748	0.137	CbGbCtD
Terbinafine—CYP2C9—Sorafenib—thyroid cancer	0.0674	0.123	CbGbCtD
Terbinafine—CYP3A4—Vandetanib—thyroid cancer	0.065	0.119	CbGbCtD
Terbinafine—CYP2D6—Sorafenib—thyroid cancer	0.0616	0.113	CbGbCtD
Terbinafine—CYP3A4—Sorafenib—thyroid cancer	0.0392	0.0717	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—thyroid cancer	0.0374	0.0684	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—thyroid cancer	0.0238	0.0435	CbGbCtD
Terbinafine—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.0075	0.0872	CbGpPWpGaD
Terbinafine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00564	0.0655	CbGpPWpGaD
Terbinafine—CYP11A1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.0055	0.0639	CbGpPWpGaD
Terbinafine—SQLE—Activation of gene expression by SREBF (SREBP)—RXRA—thyroid cancer	0.00365	0.0424	CbGpPWpGaD
Terbinafine—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00307	0.0356	CbGpPWpGaD
Terbinafine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—thyroid cancer	0.00291	0.0338	CbGpPWpGaD
Terbinafine—CYP11A1—Endogenous sterols—RXRA—thyroid cancer	0.00246	0.0285	CbGpPWpGaD
Terbinafine—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00204	0.0237	CbGpPWpGaD
Terbinafine—CYP11A1—Metapathway biotransformation—CHST14—thyroid cancer	0.00166	0.0193	CbGpPWpGaD
Terbinafine—CYP19A1—Endogenous sterols—RXRA—thyroid cancer	0.00163	0.0189	CbGpPWpGaD
Terbinafine—Tinnitus—Sorafenib—thyroid cancer	0.00157	0.00427	CcSEcCtD
Terbinafine—Dyspepsia—Vandetanib—thyroid cancer	0.00156	0.00425	CcSEcCtD
Terbinafine—Decreased appetite—Vandetanib—thyroid cancer	0.00154	0.00419	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00153	0.00417	CcSEcCtD
Terbinafine—Stinging—Epirubicin—thyroid cancer	0.00153	0.00416	CcSEcCtD
Terbinafine—Ageusia—Epirubicin—thyroid cancer	0.00153	0.00416	CcSEcCtD
Terbinafine—Fatigue—Vandetanib—thyroid cancer	0.00153	0.00416	CcSEcCtD
Terbinafine—Angiopathy—Sorafenib—thyroid cancer	0.00152	0.00416	CcSEcCtD
Terbinafine—Immune system disorder—Sorafenib—thyroid cancer	0.00152	0.00414	CcSEcCtD
Terbinafine—Pain—Vandetanib—thyroid cancer	0.00151	0.00413	CcSEcCtD
Terbinafine—Scotoma—Doxorubicin—thyroid cancer	0.00151	0.00411	CcSEcCtD
Terbinafine—Rash erythematous—Doxorubicin—thyroid cancer	0.00149	0.00407	CcSEcCtD
Terbinafine—SQLE—SREBP signalling—PPARG—thyroid cancer	0.00149	0.0173	CbGpPWpGaD
Terbinafine—Alopecia—Sorafenib—thyroid cancer	0.00149	0.00405	CcSEcCtD
Terbinafine—Blood disorder—Epirubicin—thyroid cancer	0.00148	0.00404	CcSEcCtD
Terbinafine—Mental disorder—Sorafenib—thyroid cancer	0.00147	0.00401	CcSEcCtD
Terbinafine—Liver injury—Epirubicin—thyroid cancer	0.00147	0.00401	CcSEcCtD
Terbinafine—Erythema—Sorafenib—thyroid cancer	0.00146	0.00399	CcSEcCtD
Terbinafine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00145	0.00395	CcSEcCtD
Terbinafine—Dysgeusia—Sorafenib—thyroid cancer	0.00143	0.00391	CcSEcCtD
Terbinafine—Ageusia—Doxorubicin—thyroid cancer	0.00141	0.00385	CcSEcCtD
Terbinafine—Stinging—Doxorubicin—thyroid cancer	0.00141	0.00385	CcSEcCtD
Terbinafine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00141	0.00384	CcSEcCtD
Terbinafine—Muscle spasms—Sorafenib—thyroid cancer	0.00141	0.00383	CcSEcCtD
Terbinafine—Body temperature increased—Vandetanib—thyroid cancer	0.0014	0.00381	CcSEcCtD
Terbinafine—Abdominal pain—Vandetanib—thyroid cancer	0.0014	0.00381	CcSEcCtD
Terbinafine—Blood disorder—Doxorubicin—thyroid cancer	0.00137	0.00373	CcSEcCtD
Terbinafine—Skin discolouration—Epirubicin—thyroid cancer	0.00137	0.00373	CcSEcCtD
Terbinafine—Liver injury—Doxorubicin—thyroid cancer	0.00136	0.00371	CcSEcCtD
Terbinafine—Anaemia—Sorafenib—thyroid cancer	0.00135	0.00369	CcSEcCtD
Terbinafine—Angioedema—Sorafenib—thyroid cancer	0.00134	0.00364	CcSEcCtD
Terbinafine—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00132	0.0153	CbGpPWpGaD
Terbinafine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.0013	0.00355	CcSEcCtD
Terbinafine—Cough—Sorafenib—thyroid cancer	0.00128	0.00348	CcSEcCtD
Terbinafine—Asthenia—Vandetanib—thyroid cancer	0.00127	0.00346	CcSEcCtD
Terbinafine—Skin discolouration—Doxorubicin—thyroid cancer	0.00127	0.00345	CcSEcCtD
Terbinafine—Pruritus—Vandetanib—thyroid cancer	0.00125	0.00341	CcSEcCtD
Terbinafine—Arthralgia—Sorafenib—thyroid cancer	0.00125	0.00339	CcSEcCtD
Terbinafine—Myalgia—Sorafenib—thyroid cancer	0.00125	0.00339	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00124	0.00337	CcSEcCtD
Terbinafine—Hepatocellular injury—Epirubicin—thyroid cancer	0.00124	0.00337	CcSEcCtD
Terbinafine—Dermatitis contact—Epirubicin—thyroid cancer	0.00122	0.00333	CcSEcCtD
Terbinafine—Dry mouth—Sorafenib—thyroid cancer	0.00122	0.00332	CcSEcCtD
Terbinafine—Eructation—Epirubicin—thyroid cancer	0.00122	0.00331	CcSEcCtD
Terbinafine—Diarrhoea—Vandetanib—thyroid cancer	0.00121	0.0033	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00121	0.014	CbGpPWpGaD
Terbinafine—Influenza like illness—Epirubicin—thyroid cancer	0.0012	0.00327	CcSEcCtD
Terbinafine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00119	0.00325	CcSEcCtD
Terbinafine—Infection—Sorafenib—thyroid cancer	0.00119	0.00323	CcSEcCtD
Terbinafine—Skin exfoliation—Epirubicin—thyroid cancer	0.00118	0.00322	CcSEcCtD
Terbinafine—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00117	0.0136	CbGpPWpGaD
Terbinafine—Nervous system disorder—Sorafenib—thyroid cancer	0.00117	0.00319	CcSEcCtD
Terbinafine—Dizziness—Vandetanib—thyroid cancer	0.00117	0.00319	CcSEcCtD
Terbinafine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00117	0.00319	CcSEcCtD
Terbinafine—Blood urea increased—Epirubicin—thyroid cancer	0.00117	0.00318	CcSEcCtD
Terbinafine—Skin disorder—Sorafenib—thyroid cancer	0.00116	0.00316	CcSEcCtD
Terbinafine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00114	0.00312	CcSEcCtD
Terbinafine—CYP11A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00114	0.0132	CbGpPWpGaD
Terbinafine—Anorexia—Sorafenib—thyroid cancer	0.00114	0.0031	CcSEcCtD
Terbinafine—Dermatitis contact—Doxorubicin—thyroid cancer	0.00113	0.00308	CcSEcCtD
Terbinafine—Vomiting—Vandetanib—thyroid cancer	0.00113	0.00307	CcSEcCtD
Terbinafine—Eructation—Doxorubicin—thyroid cancer	0.00112	0.00306	CcSEcCtD
Terbinafine—Rash—Vandetanib—thyroid cancer	0.00112	0.00304	CcSEcCtD
Terbinafine—Dermatitis—Vandetanib—thyroid cancer	0.00111	0.00304	CcSEcCtD
Terbinafine—Influenza like illness—Doxorubicin—thyroid cancer	0.00111	0.00303	CcSEcCtD
Terbinafine—Headache—Vandetanib—thyroid cancer	0.00111	0.00302	CcSEcCtD
Terbinafine—CYP19A1—Metapathway biotransformation—CHST14—thyroid cancer	0.0011	0.0128	CbGpPWpGaD
Terbinafine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00109	0.00298	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00109	0.00297	CcSEcCtD
Terbinafine—Blood urea increased—Doxorubicin—thyroid cancer	0.00108	0.00294	CcSEcCtD
Terbinafine—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00107	0.0124	CbGpPWpGaD
Terbinafine—Nausea—Vandetanib—thyroid cancer	0.00105	0.00287	CcSEcCtD
Terbinafine—Dyspepsia—Sorafenib—thyroid cancer	0.00105	0.00286	CcSEcCtD
Terbinafine—Decreased appetite—Sorafenib—thyroid cancer	0.00104	0.00283	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00103	0.00281	CcSEcCtD
Terbinafine—Fatigue—Sorafenib—thyroid cancer	0.00103	0.00281	CcSEcCtD
Terbinafine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00103	0.0028	CcSEcCtD
Terbinafine—Photosensitivity—Epirubicin—thyroid cancer	0.00102	0.00279	CcSEcCtD
Terbinafine—Pain—Sorafenib—thyroid cancer	0.00102	0.00278	CcSEcCtD
Terbinafine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.00101	0.0118	CbGpPWpGaD
Terbinafine—Eczema—Epirubicin—thyroid cancer	0.000999	0.00272	CcSEcCtD
Terbinafine—Hepatic failure—Epirubicin—thyroid cancer	0.000999	0.00272	CcSEcCtD
Terbinafine—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000986	0.0115	CbGpPWpGaD
Terbinafine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000976	0.00266	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000951	0.00259	CcSEcCtD
Terbinafine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000951	0.00259	CcSEcCtD
Terbinafine—Urticaria—Sorafenib—thyroid cancer	0.000949	0.00259	CcSEcCtD
Terbinafine—Photosensitivity—Doxorubicin—thyroid cancer	0.000946	0.00258	CcSEcCtD
Terbinafine—Body temperature increased—Sorafenib—thyroid cancer	0.000944	0.00257	CcSEcCtD
Terbinafine—Abdominal pain—Sorafenib—thyroid cancer	0.000944	0.00257	CcSEcCtD
Terbinafine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000939	0.00256	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000928	0.00253	CcSEcCtD
Terbinafine—CYP11A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000925	0.0107	CbGpPWpGaD
Terbinafine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000925	0.0107	CbGpPWpGaD
Terbinafine—Hepatic failure—Doxorubicin—thyroid cancer	0.000924	0.00252	CcSEcCtD
Terbinafine—Eczema—Doxorubicin—thyroid cancer	0.000924	0.00252	CcSEcCtD
Terbinafine—Hypoglycaemia—Epirubicin—thyroid cancer	0.00092	0.00251	CcSEcCtD
Terbinafine—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000915	0.0106	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000895	0.0104	CbGpPWpGaD
Terbinafine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00088	0.0024	CcSEcCtD
Terbinafine—Hypersensitivity—Sorafenib—thyroid cancer	0.00088	0.0024	CcSEcCtD
Terbinafine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000869	0.00237	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000858	0.00234	CcSEcCtD
Terbinafine—Asthenia—Sorafenib—thyroid cancer	0.000857	0.00234	CcSEcCtD
Terbinafine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000851	0.00232	CcSEcCtD
Terbinafine—Pruritus—Sorafenib—thyroid cancer	0.000845	0.0023	CcSEcCtD
Terbinafine—SQLE—Metabolism—MINPP1—thyroid cancer	0.000834	0.00969	CbGpPWpGaD
Terbinafine—Abdominal pain upper—Epirubicin—thyroid cancer	0.00082	0.00224	CcSEcCtD
Terbinafine—Diarrhoea—Sorafenib—thyroid cancer	0.000817	0.00223	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000808	0.0022	CcSEcCtD
Terbinafine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000803	0.00219	CcSEcCtD
Terbinafine—Gastritis—Epirubicin—thyroid cancer	0.000795	0.00217	CcSEcCtD
Terbinafine—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000793	0.00921	CbGpPWpGaD
Terbinafine—Dizziness—Sorafenib—thyroid cancer	0.00079	0.00215	CcSEcCtD
Terbinafine—Influenza—Epirubicin—thyroid cancer	0.000776	0.00212	CcSEcCtD
Terbinafine—Eosinophilia—Epirubicin—thyroid cancer	0.000768	0.00209	CcSEcCtD
Terbinafine—Pancreatitis—Epirubicin—thyroid cancer	0.000761	0.00207	CcSEcCtD
Terbinafine—Vomiting—Sorafenib—thyroid cancer	0.000759	0.00207	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000759	0.00207	CcSEcCtD
Terbinafine—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000756	0.00878	CbGpPWpGaD
Terbinafine—Rash—Sorafenib—thyroid cancer	0.000753	0.00205	CcSEcCtD
Terbinafine—Dermatitis—Sorafenib—thyroid cancer	0.000752	0.00205	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000748	0.00204	CcSEcCtD
Terbinafine—Headache—Sorafenib—thyroid cancer	0.000748	0.00204	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000743	0.00202	CcSEcCtD
Terbinafine—Pancytopenia—Epirubicin—thyroid cancer	0.000737	0.00201	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—thyroid cancer	0.000735	0.002	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—thyroid cancer	0.000726	0.00198	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000721	0.00197	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—thyroid cancer	0.000718	0.00196	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—thyroid cancer	0.000711	0.00194	CcSEcCtD
Terbinafine—SQLE—Metabolism—NDUFA13—thyroid cancer	0.000709	0.00824	CbGpPWpGaD
Terbinafine—Nausea—Sorafenib—thyroid cancer	0.000709	0.00193	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000708	0.00193	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—thyroid cancer	0.000704	0.00192	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—thyroid cancer	0.000702	0.00191	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—thyroid cancer	0.000692	0.00189	CcSEcCtD
Terbinafine—Infestation—Epirubicin—thyroid cancer	0.000692	0.00189	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000686	0.00187	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—thyroid cancer	0.000682	0.00186	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—thyroid cancer	0.000674	0.00184	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—thyroid cancer	0.000671	0.00183	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000667	0.00182	CcSEcCtD
Terbinafine—SQLE—Metabolism—CHST14—thyroid cancer	0.000667	0.00775	CbGpPWpGaD
Terbinafine—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000658	0.00764	CbGpPWpGaD
Terbinafine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000655	0.00179	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000654	0.00178	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—thyroid cancer	0.00065	0.00177	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—thyroid cancer	0.000646	0.00176	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—thyroid cancer	0.00064	0.00174	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—thyroid cancer	0.00064	0.00174	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000635	0.00173	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—thyroid cancer	0.000624	0.0017	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—thyroid cancer	0.000621	0.00169	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000618	0.00168	CcSEcCtD
Terbinafine—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000613	0.00711	CbGpPWpGaD
Terbinafine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00061	0.00166	CcSEcCtD
Terbinafine—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000606	0.00704	CbGpPWpGaD
Terbinafine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000605	0.00165	CcSEcCtD
Terbinafine—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000599	0.00696	CbGpPWpGaD
Terbinafine—Visual impairment—Epirubicin—thyroid cancer	0.000599	0.00163	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000597	0.00163	CcSEcCtD
Terbinafine—SQLE—SREBP signalling—AKT1—thyroid cancer	0.000589	0.00684	CbGpPWpGaD
Terbinafine—Erythema multiforme—Epirubicin—thyroid cancer	0.000587	0.0016	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—thyroid cancer	0.00058	0.00158	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—thyroid cancer	0.000579	0.00158	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—thyroid cancer	0.000575	0.00157	CcSEcCtD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.000574	0.00667	CbGpPWpGaD
Terbinafine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000572	0.00156	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000565	0.00154	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—thyroid cancer	0.000563	0.00154	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—thyroid cancer	0.000561	0.00153	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—thyroid cancer	0.000554	0.00151	CcSEcCtD
Terbinafine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000553	0.00643	CbGpPWpGaD
Terbinafine—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000553	0.00642	CbGpPWpGaD
Terbinafine—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00055	0.00639	CbGpPWpGaD
Terbinafine—Alopecia—Epirubicin—thyroid cancer	0.000549	0.0015	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—thyroid cancer	0.000544	0.00148	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000543	0.00148	CcSEcCtD
Terbinafine—Erythema—Epirubicin—thyroid cancer	0.000541	0.00147	CcSEcCtD
Terbinafine—SQLE—Metabolism—HPGD—thyroid cancer	0.000538	0.00624	CbGpPWpGaD
Terbinafine—Eye disorder—Doxorubicin—thyroid cancer	0.000537	0.00146	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—thyroid cancer	0.000536	0.00146	CcSEcCtD
Terbinafine—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000535	0.00621	CbGpPWpGaD
Terbinafine—Flatulence—Epirubicin—thyroid cancer	0.000533	0.00145	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—thyroid cancer	0.000529	0.00144	CcSEcCtD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000522	0.00606	CbGpPWpGaD
Terbinafine—Angiopathy—Doxorubicin—thyroid cancer	0.000521	0.00142	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—thyroid cancer	0.00052	0.00142	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—thyroid cancer	0.000519	0.00141	CcSEcCtD
Terbinafine—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000516	0.00599	CbGpPWpGaD
Terbinafine—Vision blurred—Epirubicin—thyroid cancer	0.00051	0.00139	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—thyroid cancer	0.000508	0.00138	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—thyroid cancer	0.000503	0.00137	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000502	0.00137	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—thyroid cancer	0.0005	0.00136	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—thyroid cancer	0.0005	0.00136	CcSEcCtD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—BRAF—thyroid cancer	0.000498	0.00579	CbGpPWpGaD
Terbinafine—Flatulence—Doxorubicin—thyroid cancer	0.000493	0.00134	CcSEcCtD
Terbinafine—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000492	0.00571	CbGpPWpGaD
Terbinafine—CYP11A1—Biological oxidations—RXRA—thyroid cancer	0.000491	0.00571	CbGpPWpGaD
Terbinafine—Dysgeusia—Doxorubicin—thyroid cancer	0.00049	0.00134	CcSEcCtD
Terbinafine—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000488	0.00566	CbGpPWpGaD
Terbinafine—Malaise—Epirubicin—thyroid cancer	0.000488	0.00133	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—thyroid cancer	0.000486	0.00132	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—thyroid cancer	0.000481	0.00131	CcSEcCtD
Terbinafine—Cough—Epirubicin—thyroid cancer	0.000472	0.00129	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—thyroid cancer	0.000471	0.00129	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000464	0.00127	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—thyroid cancer	0.000462	0.00126	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—thyroid cancer	0.00046	0.00125	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—thyroid cancer	0.00046	0.00125	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—thyroid cancer	0.00046	0.00125	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—thyroid cancer	0.000459	0.00125	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000457	0.00125	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—thyroid cancer	0.000455	0.00124	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—thyroid cancer	0.000451	0.00123	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—thyroid cancer	0.00045	0.00123	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—thyroid cancer	0.000449	0.00123	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—thyroid cancer	0.000445	0.00121	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000441	0.0012	CcSEcCtD
Terbinafine—Infection—Epirubicin—thyroid cancer	0.000438	0.00119	CcSEcCtD
Terbinafine—Cough—Doxorubicin—thyroid cancer	0.000437	0.00119	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000436	0.00506	CbGpPWpGaD
Terbinafine—Nervous system disorder—Epirubicin—thyroid cancer	0.000433	0.00118	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000432	0.00118	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—thyroid cancer	0.000429	0.00117	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—thyroid cancer	0.000426	0.00116	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—thyroid cancer	0.000426	0.00116	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—thyroid cancer	0.000426	0.00116	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—thyroid cancer	0.000424	0.00116	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000423	0.00115	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—thyroid cancer	0.000421	0.00115	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—thyroid cancer	0.000421	0.00115	CcSEcCtD
Terbinafine—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000417	0.00484	CbGpPWpGaD
Terbinafine—Dry mouth—Doxorubicin—thyroid cancer	0.000417	0.00114	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—thyroid cancer	0.000412	0.00112	CcSEcCtD
Terbinafine—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000411	0.00477	CbGpPWpGaD
Terbinafine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000408	0.00111	CcSEcCtD
Terbinafine—Infection—Doxorubicin—thyroid cancer	0.000406	0.00111	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000402	0.0011	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—thyroid cancer	0.0004	0.00109	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.0004	0.00109	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—thyroid cancer	0.000397	0.00108	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—thyroid cancer	0.000396	0.00108	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—thyroid cancer	0.000389	0.00106	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—thyroid cancer	0.000388	0.00106	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—thyroid cancer	0.000384	0.00105	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000381	0.00104	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—thyroid cancer	0.00038	0.00104	CcSEcCtD
Terbinafine—Pain—Epirubicin—thyroid cancer	0.000377	0.00103	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000372	0.00101	CcSEcCtD
Terbinafine—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000367	0.00426	CbGpPWpGaD
Terbinafine—Paraesthesia—Doxorubicin—thyroid cancer	0.000367	0.000999	CcSEcCtD
Terbinafine—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000366	0.00425	CbGpPWpGaD
Terbinafine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000365	0.00424	CbGpPWpGaD
Terbinafine—Feeling abnormal—Epirubicin—thyroid cancer	0.000364	0.000991	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—MINPP1—thyroid cancer	0.000361	0.00419	CbGpPWpGaD
Terbinafine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000361	0.000984	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—thyroid cancer	0.000359	0.00098	CcSEcCtD
Terbinafine—CYP19A1—FSH signaling pathway—AKT1—thyroid cancer	0.000357	0.00415	CbGpPWpGaD
Terbinafine—Decreased appetite—Doxorubicin—thyroid cancer	0.000355	0.000967	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000352	0.000961	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—thyroid cancer	0.000352	0.000959	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—thyroid cancer	0.000351	0.000955	CcSEcCtD
Terbinafine—Pain—Doxorubicin—thyroid cancer	0.000349	0.000952	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—thyroid cancer	0.000349	0.000951	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—thyroid cancer	0.000349	0.000951	CcSEcCtD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000346	0.00402	CbGpPWpGaD
Terbinafine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000337	0.00392	CbGpPWpGaD
Terbinafine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000336	0.000917	CcSEcCtD
Terbinafine—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000334	0.00388	CbGpPWpGaD
Terbinafine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000334	0.00091	CcSEcCtD
Terbinafine—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000333	0.00387	CbGpPWpGaD
Terbinafine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000333	0.00386	CbGpPWpGaD
Terbinafine—CYP19A1—Biological oxidations—RXRA—thyroid cancer	0.000325	0.00378	CbGpPWpGaD
Terbinafine—Hypersensitivity—Epirubicin—thyroid cancer	0.000325	0.000886	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—thyroid cancer	0.000324	0.000884	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—thyroid cancer	0.000323	0.00088	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—thyroid cancer	0.000323	0.00088	CcSEcCtD
Terbinafine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000322	0.00374	CbGpPWpGaD
Terbinafine—Asthenia—Epirubicin—thyroid cancer	0.000317	0.000863	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—thyroid cancer	0.000312	0.000851	CcSEcCtD
Terbinafine—SQLE—Metabolism—TPR—thyroid cancer	0.000309	0.00359	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—NDUFA13—thyroid cancer	0.000307	0.00356	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PRKAR1A—thyroid cancer	0.000304	0.00353	CbGpPWpGaD
Terbinafine—Diarrhoea—Epirubicin—thyroid cancer	0.000302	0.000823	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000301	0.00082	CcSEcCtD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000297	0.00345	CbGpPWpGaD
Terbinafine—Asthenia—Doxorubicin—thyroid cancer	0.000293	0.000798	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—thyroid cancer	0.000292	0.000795	CcSEcCtD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000291	0.00338	CbGpPWpGaD
Terbinafine—Pruritus—Doxorubicin—thyroid cancer	0.000289	0.000787	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—CHST14—thyroid cancer	0.000289	0.00335	CbGpPWpGaD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000286	0.00332	CbGpPWpGaD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000284	0.0033	CbGpPWpGaD
Terbinafine—Vomiting—Epirubicin—thyroid cancer	0.000281	0.000765	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—thyroid cancer	0.000279	0.000761	CcSEcCtD
Terbinafine—Rash—Epirubicin—thyroid cancer	0.000278	0.000758	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—thyroid cancer	0.000278	0.000758	CcSEcCtD
Terbinafine—Headache—Epirubicin—thyroid cancer	0.000276	0.000753	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000275	0.0032	CbGpPWpGaD
Terbinafine—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000274	0.00318	CbGpPWpGaD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000273	0.00318	CbGpPWpGaD
Terbinafine—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000271	0.00315	CbGpPWpGaD
Terbinafine—Dizziness—Doxorubicin—thyroid cancer	0.00027	0.000736	CcSEcCtD
Terbinafine—Nausea—Epirubicin—thyroid cancer	0.000262	0.000714	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—thyroid cancer	0.00026	0.000708	CcSEcCtD
Terbinafine—Rash—Doxorubicin—thyroid cancer	0.000257	0.000702	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—thyroid cancer	0.000257	0.000701	CcSEcCtD
Terbinafine—Headache—Doxorubicin—thyroid cancer	0.000256	0.000697	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—thyroid cancer	0.000243	0.000661	CcSEcCtD
Terbinafine—CYP19A1—Metabolism—MINPP1—thyroid cancer	0.000239	0.00278	CbGpPWpGaD
Terbinafine—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000236	0.00274	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—HPGD—thyroid cancer	0.000233	0.0027	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000233	0.0027	CbGpPWpGaD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000232	0.00269	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—SLC5A5—thyroid cancer	0.000231	0.00268	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000222	0.00258	CbGpPWpGaD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000221	0.00256	CbGpPWpGaD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000219	0.00255	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000217	0.00252	CbGpPWpGaD
Terbinafine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000211	0.00245	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NDUFA13—thyroid cancer	0.000203	0.00236	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000202	0.00235	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000201	0.00234	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—RXRA—thyroid cancer	0.000194	0.00226	CbGpPWpGaD
Terbinafine—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000192	0.00223	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CHST14—thyroid cancer	0.000191	0.00222	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000189	0.00219	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000189	0.00219	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000188	0.00218	CbGpPWpGaD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000179	0.00208	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000177	0.00205	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000176	0.00204	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000171	0.00199	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000168	0.00195	CbGpPWpGaD
Terbinafine—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000164	0.00191	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000162	0.00188	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CHST14—thyroid cancer	0.000161	0.00187	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000158	0.00183	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000156	0.00182	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—HPGD—thyroid cancer	0.000154	0.00179	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000153	0.00178	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000145	0.00169	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000144	0.00167	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000137	0.00159	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—TPR—thyroid cancer	0.000134	0.00155	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PRKAR1A—thyroid cancer	0.000131	0.00153	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000131	0.00152	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MINPP1—thyroid cancer	0.00013	0.00151	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—HPGD—thyroid cancer	0.00013	0.00151	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000125	0.00145	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000123	0.00143	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PPARG—thyroid cancer	0.000123	0.00142	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.00012	0.0014	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000119	0.00138	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000118	0.00137	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000116	0.00135	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	0.000111	0.00128	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000107	0.00124	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MINPP1—thyroid cancer	0.000107	0.00124	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000106	0.00123	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000105	0.00122	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CHST14—thyroid cancer	0.000104	0.00121	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—SLC5A5—thyroid cancer	0.0001	0.00116	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	9.99e-05	0.00116	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	9.86e-05	0.00115	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PTGS2—thyroid cancer	9.65e-05	0.00112	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	9.5e-05	0.0011	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.37e-05	0.00109	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CHST14—thyroid cancer	9.27e-05	0.00108	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	9.07e-05	0.00105	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MINPP1—thyroid cancer	9.04e-05	0.00105	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	9.01e-05	0.00105	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	8.99e-05	0.00104	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—TPR—thyroid cancer	8.85e-05	0.00103	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	8.7e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CHST14—thyroid cancer	8.53e-05	0.000991	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CHST14—thyroid cancer	8.46e-05	0.000982	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PTEN—thyroid cancer	8.41e-05	0.000977	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—RXRA—thyroid cancer	8.4e-05	0.000976	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HPGD—thyroid cancer	8.38e-05	0.000973	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.17e-05	0.000949	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.89e-05	0.000916	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	7.69e-05	0.000893	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HPGD—thyroid cancer	7.48e-05	0.000868	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—TPR—thyroid cancer	7.45e-05	0.000865	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PRKAR1A—thyroid cancer	7.33e-05	0.000851	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CHST14—thyroid cancer	7.23e-05	0.000839	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MINPP1—thyroid cancer	6.98e-05	0.00081	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HPGD—thyroid cancer	6.88e-05	0.000799	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HPGD—thyroid cancer	6.82e-05	0.000792	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.79e-05	0.000789	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.64e-05	0.000771	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—SLC5A5—thyroid cancer	6.62e-05	0.000769	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.21e-05	0.000721	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.06e-05	0.000704	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	5.93e-05	0.000689	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HPGD—thyroid cancer	5.83e-05	0.000677	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CHST14—thyroid cancer	5.58e-05	0.000648	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—SLC5A5—thyroid cancer	5.57e-05	0.000648	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—RXRA—thyroid cancer	5.56e-05	0.000646	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.53e-05	0.000642	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.41e-05	0.000629	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PPARG—thyroid cancer	5.3e-05	0.000616	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.22e-05	0.000607	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—AKT1—thyroid cancer	4.85e-05	0.000563	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TPR—thyroid cancer	4.81e-05	0.000559	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	4.73e-05	0.00055	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.72e-05	0.000549	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—RXRA—thyroid cancer	4.68e-05	0.000544	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.56e-05	0.000529	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HPGD—thyroid cancer	4.5e-05	0.000522	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TPR—thyroid cancer	4.29e-05	0.000499	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.29e-05	0.000498	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	4.22e-05	0.000491	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTGS2—thyroid cancer	4.17e-05	0.000485	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TPR—thyroid cancer	3.95e-05	0.000459	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TPR—thyroid cancer	3.92e-05	0.000455	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	3.89e-05	0.000451	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.85e-05	0.000447	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.83e-05	0.000445	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTEN—thyroid cancer	3.64e-05	0.000423	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	3.6e-05	0.000418	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARG—thyroid cancer	3.51e-05	0.000408	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.49e-05	0.000405	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.37e-05	0.000392	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TPR—thyroid cancer	3.35e-05	0.000389	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.29e-05	0.000382	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	3.21e-05	0.000373	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—RXRA—thyroid cancer	3.03e-05	0.000351	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.01e-05	0.00035	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.98e-05	0.000346	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—thyroid cancer	2.96e-05	0.000343	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.96e-05	0.000343	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.94e-05	0.000342	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.93e-05	0.00034	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—thyroid cancer	2.76e-05	0.000321	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.75e-05	0.000319	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—RXRA—thyroid cancer	2.7e-05	0.000314	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.63e-05	0.000305	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TPR—thyroid cancer	2.58e-05	0.0003	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.54e-05	0.000295	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.5e-05	0.000291	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—RXRA—thyroid cancer	2.48e-05	0.000288	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—RXRA—thyroid cancer	2.46e-05	0.000286	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—thyroid cancer	2.41e-05	0.00028	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.4e-05	0.000278	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.35e-05	0.000273	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—thyroid cancer	2.33e-05	0.00027	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—RXRA—thyroid cancer	2.1e-05	0.000244	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—thyroid cancer	2.1e-05	0.000244	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.05e-05	0.000238	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—thyroid cancer	2.03e-05	0.000236	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.93e-05	0.000224	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—thyroid cancer	1.91e-05	0.000222	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.71e-05	0.000198	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.62e-05	0.000189	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.57e-05	0.000182	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.55e-05	0.000181	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.5e-05	0.000175	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—thyroid cancer	1.39e-05	0.000161	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.34e-05	0.000156	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.33e-05	0.000154	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—thyroid cancer	1.31e-05	0.000152	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.23e-05	0.000143	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.22e-05	0.000142	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—thyroid cancer	1.17e-05	0.000136	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—thyroid cancer	1.17e-05	0.000136	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—thyroid cancer	1.08e-05	0.000125	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—thyroid cancer	1.07e-05	0.000124	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.000121	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.03e-05	0.000119	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—thyroid cancer	9.11e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—thyroid cancer	8.07e-06	9.37e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—thyroid cancer	7.55e-06	8.77e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—thyroid cancer	7.03e-06	8.17e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—thyroid cancer	6.74e-06	7.83e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—thyroid cancer	6.2e-06	7.2e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—thyroid cancer	6.15e-06	7.14e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—thyroid cancer	5.25e-06	6.1e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—thyroid cancer	4.05e-06	4.71e-05	CbGpPWpGaD
